Agreeable Capital: Investing in Tech and Nature-Based Solutions for Biodiversity

Agreeable Capital: Investing in Tech and Nature-Based Solutions for Biodiversity

Agreeable Capital focuses on investing in early-stage companies that develop tech and nature-based solutions to protect biodiversity and address climate change. Led by John Dennehy, the fund operates globally from its base in Ireland, supporting innovative ventures that align with sustainable development goals. With a strong advisory team and partnerships, Agreeable Capital aims to make a significant impact on the planet’s future.

Biovance Capital: Investing in Early-Stage Biopharma Companies Across Europe

Biovance Capital: Investing in Early-Stage Biopharma Companies Across Europe

Biovance Capital is dedicated to investing in disruptive, early-stage biopharma companies across Europe. Their mission is to support the development of innovative therapies that improve patient outcomes. With a focus on sustainability and a strong collaborative network, they aim to bridge the gap between research and real-world medical treatments.